G21D (p.Gly21Asp) variant of GRIA2 (Glutamate receptor 2)
G21D (p.Gly21Asp) in GRIA2 (Glutamate receptor 2) is a missense change. The available variant effect predictions contribute to a CATVariant prioritization score of 0.59 / 1. The record also includes population frequency data, published literature, and structural context.
G21D (p.Gly21Asp) variant details
- p.Gly21Asp
- gnomAD 4-157221104-G-A
- Missense
- Variant Prioritization Score for Impact Estimate 0.594
- REVEL 0.47
- CADD 24.20
- PolyPhen-2 0.71
- SIFT 0.01
- Population evidence available
- Structural context available
- Literature evidence available